UGS Announces New Releases for its D-Cubed 2D Component Software Solutions
UGS Corp., a leading global provider of product lifecycle management (PLM) software and services, and its D-Cubed subsidiary today announced the immediate availability of new releases of two of D-Cubed’s industry-leading component software products. Version 50.0 of 2D Dimensional Constraint Manager (2D DCM) and Profile Geometry Manager (PGM) contain new enhancements to improve function and performance.
Detailed descriptions of the enhancements are available online at: http://www.ugs.com/products/open/d-cubed/latest_releases.shtml.
D-Cubed
D Cubed™ software is part of the PLM Components suite of solutions and represents a family of geometric software components that enable key functionality in CAD, CAM, CAE, and PLM applications, including sketching, part and assembly modeling, motion simulation, collision detection, clearance measurement and hidden-line visualization. For more information, please visit www.ugs.com/d-cubed/.
About UGS
UGS is a leading global provider of product lifecycle management (PLM) software and services with nearly 4 million licensed seats and 46,000 customers worldwide. Headquartered in Plano, Texas, UGS’ vision is to enable a world where organizations and their partners collaborate through global innovation networks to deliver world-class products and services while leveraging UGS’ open enterprise solutions, fulfilling the mission of enabling them to transform their process of innovation.
Note: UGS, D-Cubed and Transforming the process of innovation are trademarks or registered trademarks of UGS Corp. or its subsidiaries in the United States and in other countries. All other trademarks, registered trademarks or service marks belong to their respective holders.
The statements in this news release that are not historical statements, including statements regarding expected benefits of the product, adoption by customers, continued innovation and other statements identified by forward looking terms such as „may,“ „will,“ „expect,“ „plan,“ „anticipate“ or „project,“ are forward-looking statements. These statements are subject to numerous risks and uncertainties which could cause actual results to differ materially from such statements, including, among others, risks relating to developments in the PLM industry, competition, failure to innovate, partnering strategy, major design errors or security flaws and intellectual property. UGS has included a discussion of these and other pertinent risk factors in its quarterly report on Form 10-Q for the period ended June 30, 2006 filed with the SEC. UGS disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Jonathon Rimmer
UGS
+44-1223-722-635
jonathon.rimmer@ugs.com
Media Contact
Weitere Informationen:
http://www.ugs.com/products/open/d-cubed/latest_releases.shtml http://www.ugs.com/d-cubed/Alle Nachrichten aus der Kategorie: Unternehmensmeldungen
Neueste Beiträge
Parallele Pfade: Das Verständnis von Malariaresistenz bei Schimpansen und Menschen
Die nächsten Verwandten des Menschen passen sich genetisch an Lebensräume und Infektionen an Überleben des am besten Angepassten: Genetische Anpassungen bei Schimpansen aufgedeckt Görlitz, 10.01.2025. Schimpansen verfügen über genetische Anpassungen,…
Du bist, was du isst – Stanford-Studie verbindet Ballaststoffe mit Modulation von Anti-Krebs-Genen
Die Ballaststofflücke: Ein wachsendes Problem in der amerikanischen Ernährung Ballaststoffe sind bekanntlich ein wichtiger Bestandteil einer gesunden Ernährung, doch weniger als 10 % der Amerikaner konsumieren die empfohlene Mindestmenge. Eine…
Vertrauen Sie Ihrem Bauchgefühl – RNA-Protein-Entdeckung für eine bessere Immunität
HIRI-Forscher entschlüsseln Kontrollmechanismen der Polysaccharidverwertung in Bacteroides thetaiotaomicron. Forschende des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) und der Julius-Maximilians-Universität (JMU) Würzburg haben ein Protein sowie eine Gruppe kleiner Ribonukleinsäuren (sRNAs) in…